Cargando…

The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study

BACKGROUND: Although many studies have confirmed the prognostic value of preoperative alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma (HCC), the association between AFP at baseline (b-AFP), subsequent AFP at relapse (r-AFP), and AFP alteration and overall survival in HCC patients r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qi, Liu, Biyu, Qiao, Wenying, Li, Jianjun, Yuan, Chunwang, Long, Jiang, Hu, Caixia, Zang, Chaoran, Zheng, Jiasheng, Zhang, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716397/ https://www.ncbi.nlm.nih.gov/pubmed/34976804 http://dx.doi.org/10.3389/fonc.2021.756363

Ejemplares similares

The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy
por: Wang, Qi, et al.
Publicado: (2022)

Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments
por: Sun, Yu, et al.
Publicado: (2023)

Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Interim efficacy and safety of PD-1 inhibitors in preventing recurrence of hepatocellular carcinoma after interventional therapy
por: Qiao, Wenying, et al.
Publicado: (2022)

Effect of HBsAg expression in liver tissue on prognosis of hepatocellular carcinoma after minimally invasive interventional therapy
por: Liu, Biyu, et al.
Publicado: (2023)

Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma
por: Guo, Dandan, et al.
Publicado: (2023)

Percutaneous thermal ablation combined with transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma: Efficacy and survival
por: Sun, Yu, et al.
Publicado: (2022)

Comprehensive prognostic modeling of locoregional recurrence after radiotherapy for patients with locoregionally advanced hypopharyngeal squamous cell carcinoma
por: Liu, Hongjia, et al.
Publicado: (2023)

Simple Clinical Metrics Enhance AFP to Effectively Identify Cirrhotic Patients With Complicating Hepatocellular Carcinoma at Various AFP Levels
por: Zhang, Xi, et al.
Publicado: (2020)

Efficacy of stereotactic body radiation therapy for locoregional recurrent pancreatic cancer after radical resection
por: Ji, Xiaoqin, et al.
Publicado: (2022)

A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies
por: Wang, Qi, et al.
Publicado: (2019)

New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
por: Wang, Ting, et al.
Publicado: (2020)

Establishment and validation of nomogram model for the diagnosis of AFP-negative hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2023)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
por: Lin, Zuyuan, et al.
Publicado: (2023)

Prognostic Factors and Surgery for Breast Cancer Patients With Locoregional Recurrence: An Analysis of 5,202 Consecutive Patients
por: Huang, Jiahui, et al.
Publicado: (2021)

Prognostic significance of globulin/low-density lipoprotein ratio in patients with hepatocellular carcinoma after local ablative therapy: a retrospective cohort study
por: Sun, Yu, et al.
Publicado: (2023)

Pretransplant Locoregional Therapy for Hepatocellular Carcinoma: Evaluation of Explant Pathology and Overall Survival
por: Beal, Eliza W., et al.
Publicado: (2016)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

Salvage locoregional therapies for recurrent hepatocellular carcinoma
por: Criss, Cody R, et al.
Publicado: (2023)

AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation
por: Chen, I-Hsuan, et al.
Publicado: (2023)

Locoregional Extension Patterns of Nasopharyngeal Carcinoma Detected by FDG PET/MR
por: Cao, Caineng, et al.
Publicado: (2021)

Mathematical Modeling of Locoregional Recurrence Caused by Premalignant Lesions Formed Before Initial Treatment
por: Takaki, Mitsuaki, et al.
Publicado: (2021)

Computational modeling of locoregional recurrence with spatial structure identifies tissue-specific carcinogenic profiles
por: Abubakar, Sharafudeen Dahiru, et al.
Publicado: (2023)

A CpG Methylation Signature as a Potential Marker for Early Diagnosis of Hepatocellular Carcinoma From HBV-Related Liver Disease Using Multiplex Bisulfite Sequencing
por: Li, Kang, et al.
Publicado: (2021)

A Nomogram to Predict Survival in Patients With Locoregional Recurrent Nasopharyngeal Carcinoma Receiving Comprehensive Treatment
por: Wei, Ying-Hong, et al.
Publicado: (2022)

Development and Validation of a Prognostic Nomogram in AFP-negative hepatocellular carcinoma
por: Wang, Xueping, et al.
Publicado: (2019)

Treatment Outcomes of Re-irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection
por: Chung, Seung Yeun, et al.
Publicado: (2019)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma
por: Seyedin, Steven N., et al.
Publicado: (2020)

Preoperative color Doppler ultrasonography predicts early recurrence in AFP-positive hepatocellular carcinoma
por: Chen, Miao, et al.
Publicado: (2019)

Factors Predicting Locoregional Recurrence After Neoadjuvant Chemotherapy and Nipple-Sparing/Skin-Sparing Mastectomy With Immediate Breast Reconstruction
por: Wu, Zhen-Yu, et al.
Publicado: (2021)

Individual surveillance by competing risk model for patients with hepatocellular carcinoma occurrence in all-cause cirrhosis
por: Wang, Qi, et al.
Publicado: (2023)

A prognostic index for locoregional recurrence after neoadjuvant chemotherapy
por: Herrero-Vicent, C, et al.
Publicado: (2016)

Differential Prognostic Indicators for Locoregional Recurrence, Distant Recurrence, and Death of Breast Cancer
por: Chairat, Rungnapa, et al.
Publicado: (2013)

MACC1 as a Prognostic Biomarker for Early-Stage and AFP-Normal Hepatocellular Carcinoma
por: Xie, Chan, et al.
Publicado: (2013)

Prognostic Score for De Novo Metastatic Breast Cancer With Liver Metastasis and Its Predictive Value of Locoregional Treatment Benefit
por: Ji, Lei, et al.
Publicado: (2021)

Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations
por: Zhao, Ting, et al.
Publicado: (2020)

The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort Study
por: Lee, Kyoungmin, et al.
Publicado: (2021)

Prior Local or Systemic Treatment: A Predictive Model Could Guide Clinical Decision-Making for Locoregional Recurrent Breast Cancer
por: Wu, Huai-liang, et al.
Publicado: (2022)

Anesthesia With Propofol Sedation Reduces Locoregional Recurrence in Patients With Breast Cancer Receiving Total Mastectomy Compared With Non-Propofol Anesthesia
por: Zhang, Jiaqiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n514mt5m7o3272cjhep6nio3o0